Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Marisa Lau (NPI 1396180170)

Field	Value
Entity Type	Individual
Organization	Marisa Lau
Address	1675 Aurora Ct
City	Aurora
State	CO
ZIP	80045
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 7, 2013

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

Clinical/service mix centers on intravitreal biologic therapy and ophthalmic diagnostics: the top revenue codes are J0178 (aflibercept), Q5128 (ranibizumab biosimilar), and J3590 (unclassified biologics), supported by procedure codes for intravitreal injection (67028) and retinal imaging (92134). This mix indicates a practice focused on medical retina care—regular anti-VEGF injections plus diagnostic imaging and follow-up exams—rather than primarily surgical ophthalmology.

Medicare revenue is highly concentrated in a few drug codes: the precomputed top three Medicare codes account for 58.9% of this provider's total Medicare revenue, with J0178 generating $634.1K (32.0%), Q5128 $269.1K (13.6%), and J3590 $265K (13.4%) of the $2M lifetime Medicare revenue. That concentration means movement in pricing, utilization, or payer coverage for these biologics would materially affect the provider’s Medicare receipts.

This provider is effectively single‑payer at the state level: lifetime Medicare revenue is $2M while there is no Medicaid billing on file. Absence of Medicaid activity suggests limited exposure to state program mix and potential reliance on Medicare commercial-like reimbursement dynamics.

Competitive standing on major drug codes is mixed: J0178 ranks #1348 of 3204 (58th percentile) and J3590 ranks #255 of 631 (60th percentile), both described as "typical, unremarkable volume," whereas Q5128 ranks #116 of 373 (69th percentile), indicating relatively stronger adoption or higher volume of the ranibizumab biosimilar versus national peers. Overall the provider is a modest-to-strong regional participant for certain anti‑VEGF agents rather than a national dominant provider.

Two service codes are statistical outliers upward: 92014 (comprehensive established patient exam) produced $164.5K (8.3%) and ranks in the 98th percentile (labeled an "extreme outlier"), and 92134 (retinal imaging/OCT) produced $57.1K (2.9%) and ranks in the 95th percentile ("notably above typical"). These elevated volumes suggest a high throughput of established medical retina patients and significant reliance on advanced retinal imaging as part of ongoing disease management.

Operational profile shows variation between high claim counts and low average payments for some items: for example J2777 appears in 5.3K claims but with a low $29 avg paid/claim and $153.1K revenue (7.7%), while several high‑revenue biologics have much higher avg paid/claim (e.g., J3590 at $2172 avg). This pattern implies a mix of high‑frequency, low‑unit‑value services alongside lower-frequency, high‑unit‑value drug reimbursements shaping the revenue stream.

Tenure and likely established referral base: the NPI was enumerated on 2013-05-07 (~13 years ago), indicating more than a decade of billing history. Combined with the heavy established‑patient exam volume and elevated imaging use, the data are consistent with a mature practice that has an entrenched outpatient retina/ophthalmology service line.

Revenue risk concentration is present: with $2M in Medicare revenue and no Medicaid billing, and 58.9% of Medicare revenue coming from the top three drug codes, the provider’s financial performance appears sensitive to changes in anti‑VEGF utilization, biosimilar uptake, or Medicare drug payment policies. Non‑drug services (E/M and imaging) provide complementary revenue but do not offset the concentration in biologic reimbursements.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	940	$680	$634.1K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,240	$220	$269.1K
J3590	Unclassified biologics	120	$2,170	$265K
J2778	Injection, ranibizumab, 0.1 mg	1,100	$190	$208.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,460	$110	$164.5K
J2777	Injection, faricimab‑svoa, 0.1 mg	5,280	$30	$153.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,170	$100	$122K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,590	$40	$57.1K
J3490	Unclassified drugs	30	$1,850	$53.7K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	130	$140	$17.5K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Marisa Lau — 6 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	25	60	740	$690	$618.3K
J2777	29	40	8,910	$30	$456.1K
J2778	8	20	600	$180	$199.7K
J3590	1	10	20	$2,200	$94.6K
Q5128	1	10	220	$220	$76.1K
67028	19	80	670	$100	$73.3K
J3490	55	60	50	$290	$23.1K
J7999	45	50	230	$70	$21.5K
92014	1	670	100	$80	$15.2K
92235	22	50	50	$110	$12.2K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Marisa Lau, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Physicians Incorporated	CO	Internal Medicine Physician	$0	$190.8M
Children's Hospital Colorado	CO	Children's Hospital	$0	$114.9M
Denver Health And Hospital Authority	CO	General Practice Physician	$0	$95M
Denver Health And Hospital Authority	CO	General Acute Care Hospital	$0	$77.1M
Uch-mhs	CO	General Acute Care Hospital	$0	$69M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$68.5M
University Of Colorado Hospital Authority	CO	General Acute Care Hospital	$0	$58.1M
Denver Health And Hospital Authority	CO	Ambulance	$3.4M	$46.3M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$40.3M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$29.4M

Nearby Providers

Other providers in the same ZIP code as Marisa Lau, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Prosthetic & Orthotic Group Pediatric Specialists - Colorado LLC	CO	Prosthetic/Orthotic Supplier	$0	$7.3M
University Physicians Incorporated	CO	Clinical Medical Laboratory	$0	$6.7M
Children's Optical, LLC	CO	Pediatric Optometrist	$0	$6.4M
Rmchs Management	CO	Pediatric Dentistry	$0	$4.4M
University Physicians Incorporated	CO	Clinical Medical Laboratory	$271.4K	$3.4M
Jorge Monge Urrea	CO	Hematology & Oncology Physician	$1.9M	$18.9K
University Physicians Incorporated	CO	Clinical Medical Laboratory	$509.9K	$886.9K
Rachel Chen	CO	Retina Specialist (Ophthalmology) Physician	$1M	$0
Jeffrey Olson	CO	Ophthalmology Physician	$983.2K	$0
Signal Diagnostics LLC	CO	Clinical Medical Laboratory	$976K	$0

Marisa Lau — Billing Profile & Reimbursement Data

Sign up for Marisa Lau — Billing Profile & Reimbursement Data policy alerts

Marisa Lau — Billing Profile & Reimbursement Data

Sign up for Marisa Lau — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References